medroxyprogesterone acetate has been researched along with Cognition Disorders in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (5.00) | 18.2507 |
2000's | 13 (65.00) | 29.6817 |
2010's | 6 (30.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Henderson, VW | 1 |
Brown, S | 1 |
Brinton, RD; Craft, S; Espeland, MA; Hugenschmidt, C; Jackson, RD; Johnson, KC; Manson, JE; Padula, CB; Resnick, SM; Vaughan, L; Weitlauf, J; Yaffe, K | 1 |
Colenda, CC; Espeland, MA; Fillit, H; Johnson, KC; Manson, JE; Margolis, KL; Masaki, KH; Mouton, CP; Prineas, R; Robinson, JG; Wassertheil-Smoller, S | 1 |
Bushnell, CA; Espeland, MA; Jaramillo, SA; Kuller, LH; Maldjian, JA; Margolis, KL; Melhem, ER; Mysiw, WJ; Resnick, SM; Tindle, HA | 1 |
King, J; Morrison, JH; Naftolin, F | 1 |
Acosta, JI; Bimonte-Nelson, HA; Braden, BB; Garcia, AN; Lefort, N; Mennenga, SE; Prokai, L; Simard, AR; Villa, SR | 1 |
Henderson, VW; Maki, PM | 1 |
Barrett-Connor, E; Grady, D; Kristof, M; Lin, F; Richards, C; Yaffe, K | 1 |
Bell, K; Jacobs, D; Sano, M | 1 |
Assaf, AR; Hendrix, SL; Jackson, RD; Jones, BN; Kotchen, JM; Legault, C; Ockene, JK; Rapp, SR; Shumaker, SA; Thal, L; Wactawski-Wende, J; Wallace, RB; Wassertheil-Smoller, S | 1 |
Bowen, D; Brunner, RL; Coker, LH; Dailey, M; Espeland, MA; Gass, ML; Hays, J; Henderson, VW; Johnson, KC; Lane, DS; Manson, JE; Rapp, SR; Shumaker, SA; Stefanick, ML | 1 |
Chen, CH; Huang, KE; Pai, MC; Pan, HA; Wang, ST; Wu, MH | 1 |
Culhane, NS | 1 |
Coker, LH; Fillit, H; Hendrix, SL; Kuller, L; Lane, DS; Legault, C; Lewis, CE; Masaki, K; Rapp, SR; Shumaker, SA; Stefanick, ML; Thal, L | 1 |
Brunner, R; Dailey, M; Espeland, MA; Freeman, R; Hays, J; Hogan, PE; Hsia, J; Manson, JE; Margolis, KL; Rapp, SR; Sherwin, BB; Shumaker, SA; Wallace, R | 1 |
Schneider, LS | 1 |
Coker, LH; Espeland, MA; Limacher, M; Messina, CR; Powell, LH; Rapp, SR; Resnick, SM; Wallace, R | 1 |
Burriss, SW; Gast, MJ; Maki, PM; Vieweg, AJ; Yaffe, K | 1 |
Espeland, MA; Greendale, GA; Reboussin, BA | 1 |
2 review(s) available for medroxyprogesterone acetate and Cognition Disorders
Article | Year |
---|---|
Progesterone and human cognition.
Topics: Animals; Cognition; Cognition Disorders; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Memory; Neuropsychological Tests; Postmenopause; Pregnancy; Progesterone; Progestins; Randomized Controlled Trials as Topic | 2018 |
Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on.
Topics: Aged; Aging; Alzheimer Disease; Cognition; Cognition Disorders; Dementia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Memory; Middle Aged; Postmenopause; Randomized Controlled Trials as Topic; Women's Health | 2012 |
11 trial(s) available for medroxyprogesterone acetate and Cognition Disorders
Article | Year |
---|---|
Impact of Type 2 Diabetes and Postmenopausal Hormone Therapy on Incidence of Cognitive Impairment in Older Women.
Topics: Aged; Aged, 80 and over; Brain; Cognition; Cognition Disorders; Dementia; Diabetes Mellitus, Type 2; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Glucose; Humans; Incidence; Medroxyprogesterone Acetate; Postmenopause; Randomized Controlled Trials as Topic; Risk | 2015 |
A prospective study of the effect of hypertension and baseline blood pressure on cognitive decline and dementia in postmenopausal women: the Women's Health Initiative Memory Study.
Topics: Aged; Alzheimer Disease; Blood Pressure; Calcium; Cognition Disorders; Coronary Disease; Drug Combinations; Estrogens, Conjugated (USP); Feeding Behavior; Female; Humans; Hypertension; Medroxyprogesterone Acetate; Mental Status Schedule; Middle Aged; Postmenopause; Proportional Hazards Models; Prospective Studies; Psychometrics; Risk Assessment; Risk Factors; Statistics as Topic; Vitamin D | 2008 |
Brain volumes, cognitive impairment, and conjugated equine estrogens.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Analysis of Variance; Brain; Cognition Disorders; Dementia; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Incidence; Kaplan-Meier Estimate; Logistic Models; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Neuropsychological Tests; Organ Size; Postmenopause; Prognosis; Risk Assessment; Statistics, Nonparametric | 2009 |
Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study.
Topics: Administration, Oral; Aged; Cognition; Cognition Disorders; Coronary Disease; Drug Administration Schedule; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Memory; Middle Aged; Postmenopause; Treatment Outcome | 2002 |
Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
Topics: Aged; Cognition; Cognition Disorders; Dementia; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Neuropsychological Tests; Postmenopause; Progesterone Congeners; Proportional Hazards Models; Risk | 2003 |
Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
Topics: Aged; Cognition; Cognition Disorders; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Neuropsychological Tests; Postmenopause; Progesterone Congeners; Risk | 2003 |
Cognitive function variations in postmenopausal women treated with continuous, combined HRT or tibolone. A comparison.
Topics: Cognition; Cognition Disorders; Combined Modality Therapy; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Mental Status Schedule; Middle Aged; Norpregnenes; Postmenopause; Progesterone Congeners; Single-Blind Method | 2003 |
Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
Topics: Aged; Cognition Disorders; Dementia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Incidence; Medroxyprogesterone Acetate; Postmenopause; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk | 2004 |
Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.
Topics: Aged; Cognition Disorders; Dementia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Postmenopause; Randomized Controlled Trials as Topic; Risk | 2004 |
Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial.
Topics: Cognition Disorders; Double-Blind Method; Drug Combinations; Estrogen Replacement Therapy; Estrogens; Female; Gonadal Steroid Hormones; Humans; Medroxyprogesterone Acetate; Memory; Memory Disorders; Menopause; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Placebos; Treatment Failure | 2007 |
Effect of hormone replacement therapy on self-reported cognitive symptoms: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
Topics: Cognition Disorders; Double-Blind Method; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Memory; Odds Ratio; Placebos; Postmenopause; Progestins | 1998 |
7 other study(ies) available for medroxyprogesterone acetate and Cognition Disorders
Article | Year |
---|---|
IMS updates its recommendations on the use of HRT.
Topics: Cognition; Cognition Disorders; Dementia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Progesterone Congeners | 2013 |
Post hoc magnetic resonance imaging cannot justify the conclusions of WHIMS.
Topics: Aged; Aged, 80 and over; Brain; Cognition Disorders; Dementia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Magnetic Resonance Imaging; Medroxyprogesterone Acetate | 2010 |
Cognitive-impairing effects of medroxyprogesterone acetate in the rat: independent and interactive effects across time.
Topics: Animals; Cognition Disorders; Contraceptive Agents, Female; Female; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Hippocampus; Maze Learning; Medroxyprogesterone Acetate; Memory, Short-Term; Ovariectomy; Rats; Rats, Inbred F344; Time Factors | 2011 |
Cognitive effects of estrogens in women with cardiac disease: what we do not know.
Topics: Cognition; Cognition Disorders; Coronary Disease; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Randomized Controlled Trials as Topic; Research Design | 2002 |
Estrogen plus progestin may increase incidence of dementia.
Topics: Aged; Cognition Disorders; Dementia; Double-Blind Method; Drug Combinations; Estrogen Replacement Therapy; Estrogens; Female; Humans; Incidence; Medroxyprogesterone Acetate; Postmenopause; Randomized Controlled Trials as Topic; Reproducibility of Results; United States | 2003 |
Estrogen and dementia: insights from the Women's Health Initiative Memory Study.
Topics: Aged; Cognition Disorders; Dementia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Postmenopause; Randomized Controlled Trials as Topic; Risk | 2004 |
Association between alcohol intake and domain-specific cognitive function in older women.
Topics: Aged; Alcohol Drinking; Cognition Disorders; Demography; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Middle Aged; Neuropsychological Tests; Severity of Illness Index; Women's Health | 2006 |